Drugs / Donor lymphocytes infusion (DLI)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01871441 Background | May → Dec 2013 | cancer | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Donor lymphocytes infusion (DLI) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01871441 ↗ |
| Modality | Cell therapy | “infusion of the donor's T cells” NCT01871441 ↗ |